Search icon

CYTOCYBERNETICS INC.

Company claim

Is this your business?

Get access!

Company Details

Name: CYTOCYBERNETICS INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 22 Feb 2013 (12 years ago)
Entity Number: 4364332
ZIP code: 14120
County: Niagara
Place of Formation: New York
Address: 5000 B TONAWANDA CREEK ROAD N, PENDLETON, NY, United States, 14120

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

DOS Process Agent

Name Role Address
DR RANDALL L RASMUSSON DOS Process Agent 5000 B TONAWANDA CREEK ROAD N, PENDLETON, NY, United States, 14120

U.S. Small Business Administration Profile

Phone Number:
E-mail Address:
Contact Person:
GLENNA BETT
Ownership and Self-Certifications:
Self-Certified Small Disadvantaged Business, Women-Owned Small Business, Woman Owned
User ID:
P2682516

Unique Entity ID

Unique Entity ID:
G69NH6PMLT75
CAGE Code:
756P3
UEI Expiration Date:
2025-12-04

Business Information

Activation Date:
2024-12-06
Initial Registration Date:
2014-06-16

Commercial and government entity program

CAGE number:
756P3
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-12-06
CAGE Expiration:
2029-12-06
SAM Expiration:
2025-12-04

Contact Information

POC:
GLENNA C L. BETT

Filings

Filing Number Date Filed Type Effective Date
130222000795 2013-02-22 CERTIFICATE OF INCORPORATION 2013-02-22

USAspending Awards / Contracts

Procurement Instrument Identifier:
36C24123P0881
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
41125.95
Base And Exercised Options Value:
41125.95
Base And All Options Value:
41125.95
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2023-07-11
Description:
CYBERCYTE 1.0 COMPLETE SYSTEM
Naics Code:
541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES
Procurement Instrument Identifier:
36C24E22P0021
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
20000.00
Base And Exercised Options Value:
20000.00
Base And All Options Value:
20000.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2021-12-15
Description:
CYBERCYTE DC1 DYNAMIC CLAMP SYSTEM
Naics Code:
334516: ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES

USAspending Awards / Financial Assistance

Date:
2022-07-15
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
REAL TIME NEURON SIMULATION FOR EXPERIMENTAL APPLICATIONS - THE GOAL OF THIS PROPOSAL IS TO COMBINE THE POWER OF THE NEURON MATHEMATICAL MODELING SOFTWARE WITH THE CYBERCYTE “PLUG AND PLAY” DYNAMIC CLAMP SYSTEM. OUR PRODUCT WILL ENABLE ALL NEURONAL ELECTROPHYSIOLOGISTS TO BE ABLE TO PERFORM SOPHISTICATED NEURON MODEL BASED DYNAMIC CLAMP EXPERIMENTS, WITHOUT ANY REQUIREMENT FOR PROGRAMMING, ENGINEERING, OR MATHEMATICAL MODELING SKILLS. OUR PRODUCT IS AN INTEGRATED PACKAGE OF HARDWARE AND SOFTWARE SPECIFICALLY FOR NEUROSCIENCE APPLICATIONS, FOCUSING ON THE SPECIFIC STABILITY AND RELIABILITY NEEDED FOR ROUTINE NEURONAL ELECTROPHYSIOLOGY AND THE LARGE ARRAY OF ION CHANNELS FOUND IN THE NERVOUS SYSTEM. THE FOUR AIMS OF THIS PROJECT ARE: AIM 1. IMPLEMENT AND TEST ELECTRONIC EXPRESSION MODE. IN THIS AIM, THE PATCH CLAMP AMPLIFIER IS USED IN CURRENT CLAMP MODE TO RUN CELL-BASED ACTION POTENTIALS FROM LIVE CELLS, AUGMENTED WITH COMPUTER MODELS OF SPECIFIC CHANNELS. ARTIFICIAL ION CHANNELS GENERATED BY COMPUTER MODELS ARE USED TO INJECT AN EQUIVALENT CURRENT TO MIMIC THE EFFECTS OF CHANNEL MUTATIONS, GAIN OF FUNCTION, STATE DEPENDENT DRUG BINDING ETC., TO REVEAL THEIR MECHANISMS OF ACTION ON THE EXCITABILITY OF REAL NEURONS. THIS CAN BE THOUGHT OF AS AN INEXPENSIVE “SHORT CUT” TO THE PAINSTAKING PROCESS OF GENERATING GENETIC MODELS OF ION CHANNELS AND OTHER ELECTROPHYSIOLOGICAL MODELS. AIM 2. IMPLEMENT AND TEST SYNTHETIC CELL MODE. IN SYNTHETIC CELL MODE, ALL OF THE COMPONENT CURRENTS, EXCEPT FOR THE ONE OF INTEREST, ARE MODELLED, ALONG WITH MEMBRANE ACTION POTENTIALS. THE CURRENT OF INTEREST IS THEN GENERATED IN, FOR EXAMPLE, AN HEK CELL EXPRESSING THE CHANNEL OF INTEREST AND CONTROLLED BY A VOLTAGE-CLAMP AMPLIFIER. THE COMMAND INPUT TO THE VOLTAGE CLAMP IS THE SIMULATED ACTION POTENTIAL FROM THE DYNAMIC CLAMP SYSTEM WITH THE SYNTHETIC CELL. FOR EXAMPLE, REAL DRUGS CAN BE ADDED TO THE CLONED CHANNEL OF INTEREST OR THE CONSEQUENCES OF A REAL KINETIC MUTATION CAN BE ANALYZED. AIM 3. IMPLEMENT AND DEMONSTRATE CELL COUPLING MODE. CELL COUPLING MODE WAS ARGUABLY THE FIRST FORM OF DYNAMIC CLAMP INVENTED. ORIGINALLY IT USED ANALOG CIRCUITRY TO MIMIC GAP JUNCTIONAL RESISTANCE BETWEEN CELLS. WITH NEURON, WE CAN IMPLEMENT COMPLEX FORMS OF CELL TO CELL COUPLING, INCLUDING SYNAPTIC TRANSMISSION AND INTERNEURONS. AIM 4. IMPLEMENT AND TEST DIAGNOSTICS AND EXPERIMENTAL SAFEGUARDS. A MAJOR LIMITATION OF DYNAMIC CLAMP APPLICATIONS IN RESEARCH & DEVELOPMENT, PARTICULARLY IN COMMERCIAL APPLICATIONS, IS THE DIFFICULTY IN MAINTAINING QUALITY CONTROL. THIS AIM HELPS AUTOMATE THE PROCESS OF QUALITY CONTROL TO MAKE THE SYSTEM ACCESSIBLE TO NON- SPECIALIST USERS. COMPLETION OF THESE AIMS WILL RESULT IN A COMMERCIAL ADVANCED DYNAMIC CLAMP SYSTEM WITH AN INTERFACE TO NEURON, WHICH IS POWERFUL, RELIABLE, BUT PLUG AND PLAY TO INSTALL, AND SIMPLE TO USE.
Obligated Amount:
256581.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2022-02-24
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE II: DEVELOPING A PLATFORM FOR SUPERIOR PREDICTIVE ANALYSIS OF HERG ION CHANNEL-DRUG INTERACTIONS FOR THE COMPREHENSIVE IN-VITRO PROARRHYTHMIA ASSAY (CIPA) -THE BROADER IMPACT /COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT IS TO IMPROVE DRUG SAFETY. THIS PROJECT ADVANCES SOFTWARE TO IDENTIFY THE POTENTIAL OF NEW DRUGS TO PROVOKE DANGEROUS CARDIAC SIDE-EFFECTS. BECAUSE SUDDEN CARDIAC DEATH IS AN INFREQUENT AND RELATIVELY RARE PHENOMENON, PREDICTING IT WITH CONVENTIONAL TOOLS IS EITHER IMPRACTICAL OR IMPOSSIBLE. THE PROPOSED TECHNOLOGY WILL MAKE THE DEVELOPMENT OF ALL NEW CLASSES OF DRUGS SAFER, FASTER, AND LESS EXPENSIVE. THIS WILL BE INTEGRATED INTO INVESTIGATIONAL NEW DRUG SUBMISSION PACKAGES FOR SUBMISSION TO THE FDA FOR DRUG APPROVAL. THIS WILL IMPROVE PHARMACEUTICAL SAFETY AND CLINICAL OUTCOMES. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT WILL ADDRESS THE CRITICAL PROBLEM OF PREDICTING THE ARRHYTHMOGENIC POTENTIAL OF NEW DRUGS SEEKING FDA APPROVAL. CURRENT BASIC SCIENCE RESEARCH METHODS ARE BASED ON TRYING TO REPRODUCE EXACT AND INFREQUENTLY ENCOUNTERED IN VIVO PHENOMENA IN AN IN VITRO SETTING. THE ECONOMIC AND PRACTICAL CONSTRAINTS ON DRUG DEVELOPMENT THEREFORE REQUIRES INDUSTRY TO USE PROXIES, PRIMARILY DRUG BINDING TO THE HERG POTASSIUM CHANNEL, AS A PREDICTOR ARRHYTHMOGENICITY. THE INTELLECTUAL CHALLENGE IN THIS PROJECT IS TO COMBINE MATHEMATICAL MODELING AND QUANTITATIVE ANALYSIS OF RIGOROUS EXPERIMENTAL PROTOCOLS TO BRIDGE THIS GAP AND IDENTIFY UNDERLYING FEATURES WHICH ARE STRONG PREDICTORS OF ARRHYTHMOGENIC BEHAVIOR. KEY TO UNDERSTANDING THIS IS THE RAPID DEVELOPMENT AND DEPLOYMENT OF STATE-DEPENDENT MARKOV MODELS OF DRUG ACTION BASED ON LIMITED PATCH CLAMP DATA, WHICH IS BOTH TIME-CONSUMING AND EXPENSIVE TO OBTAIN. THIS PROJECT COMBINES MATHEMATICAL ANALYSIS DIRECTLY TO DIRECT PATCH-CLAMP ASSAY PROTOCOLS TO MINIMIZE TIME AND EXPENSE WHILE INCREASING PREDICTIVE ACCURACY. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Obligated Amount:
1000000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2022-02-22
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
ADVANCED DYNAMIC CLAMP FOR NEUROSCIENCE - PROJECT SUMMARY THE GOAL OF THIS PHASE II PROPOSAL IS TO DEVELOP A COMMERCIAL “PLUG AND PLAY”, USER-FRIENDLY, POWERFUL AND RELIABLE DYNAMIC CLAMP SYSTEM SPECIFICALLY DESIGNED FOR NEURONAL APPLICATIONS. OUR PRODUCT WILL ENABLE ALL NEURONAL ELECTROPHYSIOLOGISTS TO BE ABLE TO PERFORM SOPHISTICATED DYNAMIC CLAMP EXPERIMENTS, WITHOUT ANY REQUIREMENT FOR PROGRAMMING, ENGINEERING, OR MATHEMATICAL MODELING SKILLS. OUR PRODUCT IS AN INTEGRATED PACKAGE OF HARDWARE AND SOFTWARE SPECIFICALLY FOR NEUROSCIENCE APPLICATIONS, FOCUSING ON THE SPECIFIC STABILITY AND RELIABILITY NEEDED FOR ROUTINE NEURONAL ELECTROPHYSIOLOGY AND THE LARGE ARRAY OF ION CHANNELS FOUND IN THE NERVOUS SYSTEM. IN PHASE I, WE DEVELOPED THE CRITICAL COMBINATION OF SOFTWARE, OPERATING SYSTEM, AND HARDWARE TO ACHIEVE HIGH SPEEDS, AND, MOST IMPORTANTLY, THE HIGH RELIABILITY NEEDED FOR THIS PRODUCT. THE HARDWARE AND SOFTWARE INNOVATIONS THAT MAKE THIS SYSTEM RELIABLE AND STABLE INCLUDE A DIGITALLY MODULATED CONDUCTANCE CLAMP MODE. THIS NEW INNOVATION GREATLY EXPANDS THE STABILITY OF THE SYSTEM DURING THE RAPID VOLTAGE CHANGES THAT OCCUR DURING NEURONAL ACTION POTENTIALS. OUR ADVANCES ARE MADE POSSIBLE BY PROPRIETARY SOFTWARE CONTAINING TRADE SECRETS, NOVEL PATENTED AND PATENT PENDING INSTRUMENTATION AND THE UNIQUE SKILL SET OF OUR TEAM. OUR SYSTEM IS ALSO THE FIRST DYNAMIC CLAMP SYSTEM CAPABLE OF USING CA2+ (AND OTHER FLUOROMETRIC SIGNALS) TO INTERACT WITH CURRENT AMPLITUDES AND GATING BEHAVIOR. IN PHASE I, WE FOUND THAT THE MAIN LIMITATION TO INTRODUCING OPTICAL SIGNALS INTO DYNAMIC CLAMP WAS BANDWIDTH. IN PHASE II, WE HAVE A MATCHED A PATENT-PENDING CUSTOM LOW-LATENCY PHOTODETECTOR SYSTEM THAT WE DEVELOPED EXPLICITLY FOR USE IN DYNAMIC CLAMP. THE THREE AIMS OF THIS PROJECT ARE: 1) DEVELOP GRAPHICALLY ORIENTED VALIDATED MODEL CHANNEL LIBRARIES. THIS AIM IS STRONGLY CUSTOMER DRIVEN, BASED ON FEEDBACK FROM OUR I-CORPS INTERVIEWS. THE BIGGEST BARRIER TO USING DYNAMIC CLAMP IN THE LABORATORY IS DIFFICULTY IMPLEMENTING MODELS. WE WILL MAKE DYNAMIC CLAMP AS EASY TO USE AS AN APP ON YOUR PHONE. 2) DEVELOP AND VALIDATE AN ADVANCED VERSION OF THE CYBERSOLVER FOR INTUITIVE MODEL BUILDING. WE WILL BUILD AN INTUITIVE INTERFACE THAT MATCHES HOW ELECTROPHYSIOLOGISTS ACTUALLY ANALYZE THEIR DATA. MACHINE INTELLIGENCE WILL HELP GUIDE USERS THROUGH THE PROCESS AND AVOID COMMON ERRORS. THEY WILL BE ABLE TO PRODUCE CUSTOM MODELS THAT RUN, WITHOUT PROBLEM, ON THE CYBERCYTE. 3) DEVELOP & OPTIMIZE HARDWARE FOR CUSTOMER-DRIVEN FEATURES. THIS INCLUDES THE NEED FOR MORE THAN JUST MEMBRANE VOLTAGE AS AN INPUT. WE WILL INCORPORATE OPTICAL INPUT SIGNALS. WE WILL ALSO INCLUDE FREQUENTLY REQUESTED FEATURES TO IMPROVE THE EASE OF USE, SPEED OF RESPONSE, AND AN ALTERNATE “SYNTHETIC CELL” MODE OF OPERATION. COMPLETION OF THESE AIMS WILL RESULT IN AN ADVANCED COMMERCIAL NEURONAL DYNAMIC CLAMP SYSTEM, WHICH IS POWERFUL, RELIABLE, BUT PLUG AND PLAY TO INSTALL, AND SIMPLE TO USE.
Obligated Amount:
2098299.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-01-23
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
55800.00
Total Face Value Of Loan:
55800.00
Date:
2020-07-09
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
A SYSTEM TO OPTICALLY DETERMINE THE ABSOLUTE MEMBRANE POTENTIAL IN HUMAN IPSCD CARDIAC MYOCYTES
Obligated Amount:
250000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Paycheck Protection Program

Jobs Reported:
11
Initial Approval Amount:
$55,800
Date Approved:
2020-05-01
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$55,800
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$56,370.23
Servicing Lender:
Citizens Bank, National Association
Use of Proceeds:
Payroll: $55,800
Jobs Reported:
11
Initial Approval Amount:
$55,800
Date Approved:
2021-01-22
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$55,800
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$56,131.74
Servicing Lender:
Citizens Bank, National Association
Use of Proceeds:
Payroll: $55,796
Utilities: $1

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 26 Mar 2025

Sources: New York Secretary of State